Acute Respiratory Tract Infection — Reducing Antibiotic Prescribing in Family Practice
Citation(s)
Ajzen I, Madden TJ Prediction of goal-directed behavior: attitudes, intentions, and perceived behavioral control. Journal lof Experimental Social Psychology. 1986;22:453-474.
Barnett ML, Linder JA Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. JAMA. 2014 May 21;311(19):2020-2. doi: 10.1001/jama.2013.286141.
Basu, A Estimating costs and valuations of non-health benefits. 2nd ed. New York: Oxford University Press; 2017.
Brennan-Krohn T, Ozonoff A, Sandora TJ Adherence to guidelines for testing and treatment of children with pharyngitis: a retrospective study. BMC Pediatr. 2018 Feb 9;18(1):43. doi: 10.1186/s12887-018-0988-z.
Cabral C, Horwood J, Hay AD, Lucas PJ How communication affects prescription decisions in consultations for acute illness in children: a systematic review and meta-ethnography. BMC Fam Pract. 2014 Apr 8;15:63. doi: 10.1186/1471-2296-15-63. Review.
Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010 May 18;340:c2096. doi: 10.1136/bmj.c2096. Review.
Davis DA, Thomson MA, Oxman AD, Haynes RB Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995 Sep 6;274(9):700-5.
Deyo RA, Cherkin DC, Ciol MA Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613-9.
Hersh AL, Shapiro DJ, Pavia AT, Fleming-Dutra KE, Hicks LA Geographic Variability in Diagnosis and Antibiotic Prescribing for Acute Respiratory Tract Infections. Infect Dis Ther. 2018 Mar;7(1):171-174. doi: 10.1007/s40121-017-0181-y. Epub 2017 Dec 22.
Hersh AL, Shapiro DJ, Pavia AT, Shah SS Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011 Dec;128(6):1053-61. doi: 10.1542/peds.2011-1337. Epub 2011 Nov 7.
Raudenbush SW, Bryk AS Heirarchical linear models: applications and data analysis methods. 2nd ed: Sage; 2002.
Shapiro DJ, Hicks LA, Pavia AT, Hersh AL Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother. 2014 Jan;69(1):234-40. doi: 10.1093/jac/dkt301. Epub 2013 Jul 25.
Simon TD, Haaland W, Hawley K, Lambka K, Mangione-Smith R Development and Validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 3.0. Acad Pediatr. 2018 Jul;18(5):577-580. doi: 10.1016/j.acap.2018.02.010. Epub 2018 Feb 26.
Stivers T Non-antibiotic treatment recommendations: delivery formats and implications for parent resistance. Soc Sci Med. 2005 Mar;60(5):949-64.
Tang S Profile of Pediatric Visits 2004-2007. American Academy of Pediatrics, 2010.
Tyrstrup M, Melander E, Hedin K, Beckman A, Mölstad S Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption. BMC Infect Dis. 2017 Sep 4;17(1):603. doi: 10.1186/s12879-017-2703-3.
Xu X, Grossetta Nardini HK, Ruger JP Micro-costing studies in the health and medical literature: protocol for a systematic review. Syst Rev. 2014 May 21;3:47. doi: 10.1186/2046-4053-3-47.
Dialogue Around Respiratory Illness Treatment for Family Practice (DART -FP)
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.